A Yeast-Based Platform for Oral Delivery of a Dual GLP-1/GIP Receptor Agonist: Engineering and Preliminary Clinical Evaluation
Oral delivery of peptides and other biologics is limited by enzymatic degradation and poor intestinal permeability. We developed a Saccharomyces cerevisiae